Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Cosford ND, Tehrani L, Roppe J, et al. (January 2003). „3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity”. J. Med. Chem.46 (2): 204–6. DOI:10.1021/jm025570j. PMID12519057.
Iso Y, Grajkowska E, Wroblewski JT, et al. (February 2006). „Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications”. J. Med. Chem.49 (3): 1080–100. DOI:10.1021/jm050570f. PMID16451073.
Cosford ND, Tehrani L, Roppe J, et al. (January 2003). „3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity”. J. Med. Chem.46 (2): 204–6. DOI:10.1021/jm025570j. PMID12519057.
Iso Y, Grajkowska E, Wroblewski JT, et al. (February 2006). „Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications”. J. Med. Chem.49 (3): 1080–100. DOI:10.1021/jm050570f. PMID16451073.